Company intelligence / Profile preview

Citrano Medical Laboratories

Towson, Maryland, United States

Ownership: Private
Employees: ~170
Development stage: Other

Overview

The company operates a CLIA-certified laboratory specializing in synovial fluid testing for joint infection diagnosis. The Synovasure test, developed for periprosthetic joint infection diagnosis, was launched commercially in November 2013 and has been well-received by orthopedic surgeons across the United States.

Therapeutic areas: ImmunologyRheumatologyInfectious Diseases
Modalities: Biomarker assaysImmunoassays
Industry: Protein Biomarker Diagnostics

Partnerships

Zimmer (collaboration on Synovasure development)

Beyond the preview

Go deeper on Citrano Medical Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Citrano Medical Laboratories.

Explore the full profile